NCT06569654

Brief Summary

Objective: The SaeboFlex orthosis is designed to assist individuals with upper extremity weakness in performing repetitive tasks. This study is planned to evaluate its effectiveness in improving upper extremity functions in stroke patients. Methods: A randomized controlled study is planned to be conducted with 30 stroke patients, who will be divided into a control group (15 patients) and an intervention group (15 patients). The intervention group will receive task-oriented training with the SaeboFlex splint for 12 weeks, twice a week for 45 minutes, in addition to regular rehabilitation. The control group will continue with standard rehabilitation. Planned outcome measures include the Brunnstrom Stages, Stroke Impact Scale, Fugl-Meyer Assessment, Action Research Arm Test, joint range of motion, and Beck Depression Inventory. Non-parametric tests will be used for statistical analysis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
Completed

Started Feb 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 10, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2023

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

August 19, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 26, 2024

Completed
Last Updated

August 26, 2024

Status Verified

August 1, 2024

Enrollment Period

10 months

First QC Date

August 19, 2024

Last Update Submit

August 21, 2024

Conditions

Keywords

Occupational therapyActivities daily livingNeurorehabilitation

Outcome Measures

Primary Outcomes (6)

  • Action Research Arm Test (ARAT)

    The ARAT is a widely used, validated, and reliable measure of upper extremity function. It includes four subscales: grip, grasp, pinch, and gross motor movements. The highest total score is 57, indicating the best performance

    Through study completion, an average of 1.5 year

  • Joint Range of Motion

    Goniometry is used to assess joint range of motion of the trunk, and flexion and extension degrees are recorded.

    Through study completion, an average of 1.5 year

  • Loewenstein Occupational Therapy Cognitive Assessment (LOTCA)

    The LOTCA test is used to evaluate individuals' cognitive abilities before and after intervention. It consists of 22 items grouped into two assessments: pre-treatment and post-treatment. The test assesses orientation, visual-spatial perception, visual-motor organization, thinking skills, and attention. Performance on each subtest and total scores are calculated. In our study, we evaluated only the visual-motor organization and visual-spatial perception parameters

    Through study completion, an average of 1.5 year

  • Beck Depression Inventory (BDI)

    This 21-item scale is used to assess the level of depression. Each question is scored from 0 to 3, resulting in a total score ranging from 0 to 63. Scores between 0-13 indicate no depression, 14-24 indicate moderate depression, and scores above 25 indicate severe depression. The scale has been validated and adapted for the Turkish population

    Through study completion, an average of 1.5 year

  • Barthel Index (BI)

    The Barthel Index, developed by Barthel and Mahoney in 1965, is a reliable and valid instrument used to assess individuals' independence in activities of daily living. In this study, the index was used to determine the level of independence in daily activities. The index scores range from 0 to 100, with scores of 0-20 indicating complete dependence, 21-61 indicating severe dependence, 62-90 indicating moderate dependence, 91-99 indicating mild dependence, and 100 indicating independence

    Through study completion, an average of 1.5 year

  • Fugl-Meyer Assessment for Upper Extremity

    This quantitative impairment index measures sensorimotor recovery following stroke based on Twitchell and Brunnstrom's motor recovery stages. The assessment evaluates motor function, balance, sensation, joint range of motion, and pain across five domains. The total score is 226, and the motor score ranges from 0 to 100. The assessment measures reflex movements of the shoulder, elbow, forearm, wrist, hand, hip, knee, and ankle. The highest score for the upper extremity is 66, and for the lower extremity is 34

    Through study completion, an average of 1.5 year

Secondary Outcomes (3)

  • Brunnstrom Stages

    Before intervention for inclusion stage

  • Mini-Mental State Examination (MMSE)

    Before intervention for inclusion stage

  • Stroke Impact Scale (SIS)

    Before intervention for inclusion stage

Study Arms (2)

Intervention group

EXPERIMENTAL

The intervention group received additional task-oriented repetitive training using the SaeboFlex orthosis, a dynamic wrist-hand-finger orthosis designed to facilitate upper limb rehabilitation in stroke participants. The SaeboFlex orthosis is a custom-fabricated, non-electric mechanical device that assists participants with significant upper extremity weakness, particularly those without active finger extension, in performing repetitive task practice

Device: Saebo splint

Control group

NO INTERVENTION

Both the control and intervention groups received regular rehabilitation, which included physical therapy, occupational therapy and visual cognitive rehabilitation. During the regular rehabilitation program, participants received a comprehensive range of therapies aimed at improving their overall functional abilities and quality of life. The key components of the regular rehabilitation included:

Interventions

The SaeboFlex orthosis was fitted individually for each participant in the intervention group. The orthosis was adjusted to ensure proper alignment and comfort. Participants were instructed on how to don and doff the orthosis correctly and safely. The orthosis positions the wrist and fingers in extension in preparation for grasp and release activities, enabling participants to perform functional tasks despite limited voluntary movement. Task-Oriented Repetitive Training: The intervention consisted of 45-minute sessions, conducted twice a week, over a period of 12 weeks. Each session focused on repetitive, task-oriented exercises designed to improve motor function and enhance neuroplasticity. Training Activities: * Moving the Ball * Bringing the Ball to the Mouth * Reaching Towards a Target * Manipulating the Ball Around a Target * Placing the Ball into Tubes * Throwing the Ball * Catching a Rolling Ball

Also known as: Task-Oriented Repetitive Training
Intervention group

Eligibility Criteria

Age45 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Stroke occurrence at least 6 months prior
  • Score of 23 or higher on the Standardized Mini Mental Test
  • Brunnstrom stage 2 or 3
  • Ability to maintain sitting balance
  • Active shoulder and elbow flexion of 15 degrees or more
  • Wrist extension with finger extension of 15 degrees or more
  • Active finger flexion up to 25% of a full fist position

You may not qualify if:

  • Presence of another neurological, orthopedic, or psychiatric problem causing activity limitation
  • Previous use of the method being studied

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fenerbahçe University

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

StrokeDepression

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesBehavioral SymptomsBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized controlled study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof.

Study Record Dates

First Submitted

August 19, 2024

First Posted

August 26, 2024

Study Start

February 10, 2022

Primary Completion

December 20, 2022

Study Completion

June 15, 2023

Last Updated

August 26, 2024

Record last verified: 2024-08

Locations